TRI LOCUM PARTNERS LP Nektar Therapeutics Transaction History

TRI LOCUM PARTNERS LP portfolio value:

$0
portfolio value

TRI LOCUM PARTNERS LP quarter portfolio value change:

-15.79%
quarter

Nektar Therapeutics 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share Decrease -100.00% -13.40K shares -51K $3.2 0
Q2 2022 share Increase 0.00% 13.40K shares 51K $3.8 13.40K